3H-吲哚-2-羧酸 | 294636-73-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 3H-吲哚-2-羧酸
• 英文名称: 3H-Indole-2-carboxylic acid
• CAS: 294636-73-0
• 化学式: C₉H₇NO₂
• mdl: MFCD09746138
• 分子量: 161.16
• InChiKey: UDFORAXSNZZHCQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.111
• 拓扑面积：
  49.7
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• [EN] SQUARAINE DYES AND APPLICATIONS THEREOF<br/>[FR] COLORANTS SQUARAÏNE ET LEURS APPLICATIONS
  申请人：COUNCIL SCIENT IND RES

  公开号：WO2018020518A1

  公开（公告）日：2018-02-01

  The present invention disclosed a squaraine dye of formula (I) and process for the preparation thereof. Further, the present invention disclosed to an electronic device comprising dye of formula (I).

  本发明揭示了一种式（I）的方酮染料以及其制备方法。此外，本发明还揭示了一种包括式（I）染料的电子设备。
• DYE-SENSITIZED SOLAR CELL, PHOTOELECTRIC CONVERSION ELEMENT, AND DYE FOR USE IN THE SOLAR CELL AND THE ELEMENT
  申请人：Hayase Shuzi

  公开号：US20120029206A1

  公开（公告）日：2012-02-02

  Provided are a squarylium dye having a carboxyindolenine structure and an N-alkyl substituent, and a photoelectric conversion element having high photoelectric conversion efficiency in a near-infrared region and a dye-sensitized solar cell, both of which are produced using the squarylium dye. The photoelectric conversion element or dye-sensitized solar cell uses a compound represented by the formula (1) as the squarylium dye. In the formula (1), R 1 and R 2 represent a substituted or unsubstituted C5 to C30 alkyl group; X represents C(CH 3 ) 2 ; and A and B represent a carboxy group.

  提供一种具有羧基吲哚啉结构和N-烷基取代基的方酰胺染料，以及使用该方酰胺染料制备的在近红外区域具有高光电转换效率的光电转换元件和染料敏化太阳能电池。光电转换元件或染料敏化太阳能电池使用代表式（1）所示的化合物作为方酰胺染料。在式（1）中，R1和R2代表取代或未取代的C5至C30烷基；X代表C(CH3)2；A和B代表羧基。
• [EN] NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS<br/>[FR] LIGANDS DU RECEPTEUR A L'ACETYLCHOLINE NICOTINIQUE
  申请人：ASTRAZENECA AB

  公开号：WO2005061510A1

  公开（公告）日：2005-07-07

  Acetylcholine receptor ligands of formula (I), wherein D, Ar1, E and Ar2 are as described in the specification, diastereoisomers, enantiomers, pharmaceutically-acceptable salts, methods of making, pharmaceutical compositions containing and methods for using the same.

  乙酰胆碱受体配体的化学式（I），其中D、Ar1、E和Ar2如规范中所述，对映异构体，对映体，药用盐，制备方法，含有该化合物的药物组合物以及使用该化合物的方法。
• Nicotinic Acetylcholine Receptor Ligands
  申请人：Ernst Glen

  公开号：US20070249588A1

  公开（公告）日：2007-10-25

  Acetylcholine receptor ligands of formula (I), wherein D, Ar1, E and Ar2 are as described in the specification, diastereoisomers, enantiomers, pharmaceutically-acceptable salts, methods of making, pharmaceutical compositions containing and methods for using the same.

  公式（I）的乙酰胆碱受体配体，其中D，Ar1，E和Ar2如规范所述，对映异构体，对映体，药学上可接受的盐，制备方法，包含制剂和使用方法的药物组合物。
• UNSATURATED NITROGEN HETEROCYCLIC COMPOUNDS USEFUL AS PDE10 INHIBITORS
  申请人：ALLEN Jennifer R.

  公开号：US20110306587A1

  公开（公告）日：2011-12-15

  Unsaturated nitrogen heterocyclic compounds of formula (I): as defined in the specification, compositions containing them, and processes for preparing such compounds. Provided herein also are methods of treating disorders or diseases treatable by inhibition of PDE10, such as obesity, Huntington's Disease, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like.

  式(I)的不饱和氮杂环化合物，如本说明书中所定义的，含有它们的组合物以及制备这种化合物的方法。本文还提供了治疗可通过抑制PDE10治疗的疾病或疾病的方法，例如肥胖症，亨廷顿病，非胰岛素依赖性糖尿病，精神分裂症，双相情感障碍，强迫症等。